On March 4, 2021 Herantis Pharma Plc ("Herantis"), an innovative clinical stage biotech company pioneering new disease modifying and regenerative biologic and gene therapies, reported that Craig Cook, Chief Executive Officer, will be participating at the upcoming virtual investor conferences, where he will be presenting and holding 1×1 meetings (Press release, Herantis Pharma, MAR 4, 2021, View Source,c3299929 [SID1234577484]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: H.C. Wainwright Global Life Sciences Conference

Format: Presentation & 1×1’s

Dates: March 9 – 10, 2021

Webcasting link: View Source

The session time is on-demand and is for March 9 starting at 7:00 am (EST), archived for 90 days.

Event: Carnegie Nordic Healthcare Virtual Seminar 2021

Format: Presentation & 1×1’s

Dates: March 9 – 12, 2021

Presentation: March 12th, 2021 at 09:00 a.m. CET/ 10:00 a.m. EET

Event: BIO-Europe Spring Digital 2021

Format: Presentation & 1×1’s

Dates: March 22 – 25, 2021

Presentation: On-demand after March 22, 2021 when registered for BIO-Europe Spring Digital 2021